ParagonRx Webinar to Provide Insight on the Institute of Medicine's Report Titled, Ethical and Scientific Issues in Studying the Safety of Approved Drugs

NEWARK, Del.--(BUSINESS WIRE)--A complimentary webinar will be presented by ParagonRx on the IOM Report Brief released in May 2012 describing the content of a new report the IOM released in a pre-publication version entitled, Ethical and Scientific Issues in Studying the Safety of Approved Drugs.